Staff Members - Benha University
Serum adiponectin level in obese and non-obese COPD patients during acute exacerbation and stable conditions
• 2014
Publication Information
Authors
Magdy Mohammad Omar a,1 Hesham Ali Issa b,2 Ahmad Abdelsadek Mohammad a,1 Moustafa Abd-Elaty Abd-Elhamid c,3
Keywords
Not Available
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
International
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
Aim of the work: To assess serum adiponectin in obese & non obese COPD during exacerbation and stable conditions and its relation to ventilatory functions.
Subjects and Methods: The study was conducted on 40 male COPD patients during exacerbation and stable conditions with 15 age matched healthy control subjects. Patients and control were divided into non-obese and obese according to their body mass index. Subjects were submitted to full history taking, Complete physical examination, plain chest X-ray, Complete blood count, Erythrocyte sedimentation rate, Liver and kidney functions, Fasting and post prandial blood sugar,Ventilatory functions, and Venous blood samples for Adiponectin measurement.
Results: There was Significant difference in serum adiponectin between exacerbated nonobese
COPD and nonobese controls (P < 0.005) and significant difference in serum adiponectin between exacerbated obese COPD patients and obese controls (P < 0.05). Significant difference was observed in serum adiponectin between nonobese stable COPD and nonobese controls(P
Subjects and Methods: The study was conducted on 40 male COPD patients during exacerbation and stable conditions with 15 age matched healthy control subjects. Patients and control were divided into non-obese and obese according to their body mass index. Subjects were submitted to full history taking, Complete physical examination, plain chest X-ray, Complete blood count, Erythrocyte sedimentation rate, Liver and kidney functions, Fasting and post prandial blood sugar,Ventilatory functions, and Venous blood samples for Adiponectin measurement.
Results: There was Significant difference in serum adiponectin between exacerbated nonobese
COPD and nonobese controls (P < 0.005) and significant difference in serum adiponectin between exacerbated obese COPD patients and obese controls (P < 0.05). Significant difference was observed in serum adiponectin between nonobese stable COPD and nonobese controls(P